Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer

BACKGROUND: The effects of subclinical hyperthyroidism on fracture risk induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with thyroid cancer still remains controversial. We performed a meta-analysis and systematic review to evaluate the effects of TSH suppression therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Youjin, Yoon, Byung-Ho, Lee, Seeyoun, Chung, Youn Kyung, Lee, Young-Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416149/
https://www.ncbi.nlm.nih.gov/pubmed/30899724
http://dx.doi.org/10.11005/jbm.2019.26.1.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416149/
https://www.ncbi.nlm.nih.gov/pubmed/30899724
http://dx.doi.org/10.11005/jbm.2019.26.1.45

Ejemplares similares